L162441 is primarily used in pharmacological research to investigate its mechanism of action and effects in the body, with a focus on anti-inflammatory properties and immune system modulation.

Additionally, it is being studied for its potential in developing new drugs to treat chronic inflammatory conditions or autoimmune diseases.

Preliminary research highlights the potential of L162441 to inhibit enzymes or proteins involved in inflammatory processes, which could lead to novel treatment approaches in the future.

However, its applications remain in the experimental phase, requiring further studies to validate efficacy and safety before clinical use.

As a versatile intermediate in organic synthesis, it supports the development of active pharmaceutical ingredients (APIs) and aids in exploring new chemical reactions.